Previous studies have suggested that an increased androgen receptor positivity is a risk factor in the development of breast cancers in female-male transexuals and few cases of breast cancer were reported in transgender males receiving testosterone therapy for gender-affirming hormonal treatment [19, 20]. This evidence concerns the gene AR and breast cancer.